Literature DB >> 22290355

Growth and development: patching up a better pill for GH-deficient women.

Vita Birzniece, Ken K Y Ho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22290355     DOI： 10.1038/nrendo.2012.9

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Biologic effects of transdermal estradiol.

Authors:  R J Chetkowski; D R Meldrum; K A Steingold; D Randle; J K Lu; P Eggena; J M Hershman; N K Alkjaersig; A P Fletcher; H L Judd
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

2.  Estrogen replacement in women of fertile years with hypopituitarism.

Authors:  P M Mah; J Webster; P Jönsson; U Feldt-Rasmussen; M Koltowska-Häggström; R J M Ross
Journal:  J Clin Endocrinol Metab       Date:  2005-08-09       Impact factor: 5.958

3.  Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.

Authors:  K E Friend; M L Hartman; S S Pezzoli; J L Clasey; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1996-06       Impact factor: 5.958

4.  Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: a randomized study.

Authors:  Ana Lúcia Isotton; Maria Celeste Osorio Wender; Alessandra Casagrande; Guilherme Rollin; Mauro Antônio Czepielewski
Journal:  Eur J Endocrinol       Date:  2011-11-22       Impact factor: 6.664

5.  Comparison of pharmacodynamic properties of various estrogen formulations.

Authors:  C A Mashchak; R A Lobo; R Dozono-Takano; P Eggena; R M Nakamura; P F Brenner; D R Mishell
Journal:  Am J Obstet Gynecol       Date:  1982-11-01       Impact factor: 8.661

6.  Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women.

Authors:  James Gibney; Gudmundur Johannsson; Kin-Chuen Leung; Ken K Y Ho
Journal:  J Clin Endocrinol Metab       Date:  2005-04-26       Impact factor: 5.958

7.  Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women.

Authors:  T Wolthers; D M Hoffman; A G Nugent; M W Duncan; M Umpleby; K K Ho
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-12       Impact factor: 4.310

8.  Differential effects of raloxifene and estrogen on body composition in growth hormone-replaced hypopituitary women.

Authors:  Vita Birzniece; Udo J Meinhardt; James Gibney; Gudmundur Johannsson; Nicola Armstrong; Robert C Baxter; Ken K Y Ho
Journal:  J Clin Endocrinol Metab       Date:  2011-12-14       Impact factor: 5.958

9.  Quantification of the adverse effect of ethinylestradiol containing oral contraceptive pills when used in conjunction with growth hormone replacement in routine practice.

Authors:  Niamh Phelan; Sophy H Conway; Sofia Llahana; Gerard S Conway
Journal:  Clin Endocrinol (Oxf)       Date:  2012-05       Impact factor: 3.478

Review 10.  Estrogen regulation of growth hormone action.

Authors:  Kin-Chuen Leung; Gudmundur Johannsson; Gary M Leong; Ken K Y Ho
Journal:  Endocr Rev       Date:  2004-10       Impact factor: 19.871
  10 in total
  1 in total

Review 1.  Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies.

Authors:  Jennifer C Stone; Justin Clark; Ross Cuneo; Anthony W Russell; Suhail A R Doi
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.